Has Humaira Hussain, MD received payments from drug or device companies?

Yes. Drug and device makers reported $507 in general payments to Humaira Hussain, MD across 21 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Humaira Hussain, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Humaira Hussain, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Humaira Hussain, MD

Rheumatology · Voorhees, NJNPI 1194904409

Payments from drug & device makers

$507in general payments, 2019–2025

Across 21 payments — averaging $24.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$250
Amgen$91
AbbVie$37
Aurinia Pharma U.S., Inc.$35
Pfizer$26
GSK$22
plus $45 from 3 others

What the payments were for

Food & beverage$35670%
Education$15230%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	4	$250
Amgen	6	$91
AbbVie	3	$37
Aurinia Pharma U.S., Inc.	2	$35
Pfizer	2	$26
GSK	1	$22
Novartis	1	$18
Genentech USA, Inc.	1	$15
AstraZeneca	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Tremfya$100

How this compares

$507 in reported general payments places this provider in the 25th percentile of 234 rheumatology providers in New Jersey.

See all rheumatology providers in New Jersey →

Medicare billing

Part B allowed, 2024

$144,252

Medicare patients

233

Services billed

6,657

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Humira(Cf) PenAdalimumab	27	$212,246
TymlosAbaloparatide	13	$34,564
Hydroxychloroquine Sulfate	98	$5,552
Gabapentin	208	$3,616
MethotrexateMethotrexate Sodium	138	$3,044
Leflunomide	28	$1,929
Colchicine	29	$1,381
Tizanidine Hcl	97	$862
Prednisone	139	$820
Celecoxib	13	$773
Azathioprine	13	$742
Alendronate Sodium	101	$706
Sulfasalazine	31	$628
Pregabalin	32	$603
Allopurinol	40	$488

Paid to pharmacies, not to this prescriber.

Other rheumatology in Voorhees

Joshua SundharVoorhees$1.3M
Adrienne HollanderVoorhees$441K
Mugdha AgrawalVoorhees$52K
Sheldon SolomonVoorhees$36K
James DwyerVoorhees$35K
Shawn AbrahamVoorhees$34K
Arielle SilverVoorhees$18K
Neil KramerSummit$1.8M
Lori CoxNew Brunswick$1.4M
Richard HaddadRed Bank$1.1M

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →